Clinical Trials Browser

Phase 3 × Terminated × Injections × Clear all

NCT03936933 2025-02-17

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Phase 3 Terminated

Breast Neoplasms